Global Longlife Hospital and Research Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Global Longlife Hospital and Research Ltd. on BSE

Search Inside the pdf :

Global Longlife Hospital and Research Ltd.

28 Apr 2025

30.97

4.98%

Board Meeting

Global Longlife Hospital and Research Ltd - 543520 - Board Meeting Outcome for Consideration And Approval …

BSE India

Outcome of Meeting of Board of Directors held today i.e. Monday, April 28, 2025, in terms of Regulation 30 of SEBI (LODR) Regulations, 2015, for Consideration and approval of Audited Financial Results for the Half Year and Year ended on March 31, 2025 along with Audit Report.

pdf

Global Longlife Hospital and Research Ltd.

28 Apr 2025

30.97

4.98%

Result

Global Longlife Hospital and Research Ltd - 543520 - Audited Financial Results For The Half Year …

BSE India

Audited Financial Results for the Half year and year ended March 31, 2025

pdf

Global Longlife Hospital and Research Ltd.

23 Apr 2025

30.97

4.98%

Company Update

Global Longlife Hospital and Research Ltd - 543520 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Clarification for Non-Applicability of Regulation 24(A) of SEBI LODR Regulations, 2015 for the year ended march 31, 2025.

pdf

Global Longlife Hospital and Research Ltd.

21 Apr 2025

30.97

4.98%

Board Meeting

Global Longlife Hospital and Research Ltd - 543520 - Board Meeting Intimation for Consideration Of Audited …

BSE India

Global Longlife Hospital And Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2025 ,inter alia, to consider and approve The Audited Financial Results for the Half year and Year ended on 31 March 2025.

pdf

Global Longlife Hospital and Research Ltd.

17 Apr 2025

30.97

4.98%

Corp. Note

Global Longlife Hospital and Research Ltd - 543520 - Format of the Initial Disclosure to be …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyGlobal Longlife Hospital and Research Ltd 2CIN NO.L85110GJ2012PLC068700 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 3.41 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Tanvi Solanki Designation: Company Secretary and Compliance Officer EmailId: investor@globalhospital.co.in Name of the Chief Financial Officer: Hetal Thakkar Designation: Chief Financial Officer EmailId: account@globalhospital.co.in Date: 17/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Global Longlife Hospital and Research Ltd.

10 Apr 2025

30.97

4.98%

Company Update

Global Longlife Hospital and Research Ltd - 543520 - Compliances-Certificate under Reg. 74 (5) of SEBI …

BSE India

Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, We hereby submit the certificate for the quarter ended on March 31, 2025 received from Bigshare Services Private Limited, Registrar and Share Transfer Agent (RTA) of the company.

pdf

Global Longlife Hospital and Research Ltd.

27 Mar 2025

30.97

4.98%

SAST

Global Longlife Hospital and Research Ltd - 543520 - Closure of Trading Window

BSE India

The Trading Window for dealing in the Securities of the Company will be closed for all the insiders including the Designated Persons of the Company from Tuesday, 01st April, 2025 till 48 hours after the declaration of the Audited Financial results of the Company for the Half year and Year ended on March 31, 2025.

pdf

Global Longlife Hospital and Research Ltd.

16 Jan 2025

30.97

4.98%

Company Update

Global Longlife Hospital and Research Ltd - 543520 - Compliances-Certificate under Reg. 74 (5) of SEBI …

BSE India

We hereby submit the certificate under regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended on December 31, 2024, received from Bigshare Services Private Limited Registrar and Share Transfer Agent (RTA) of the Company.

pdf